Enrolling by invitationNCT06276764

The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)

Studying Intraductal papillary mucinous carcinoma of pancreas

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Adenocyte, LLC
Principal Investigator
Gregory Haber, MD FRCP
Manhattan Endoscopy Center
Intervention
LINFU®(diagnostic_test)
Enrollment
500 target
Eligibility
18-90 years · All sexes
Timeline
20242034

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06276764 on ClinicalTrials.gov

Other trials for Intraductal papillary mucinous carcinoma of pancreas

Additional recruiting or active studies for the same condition.

See all trials for Intraductal papillary mucinous carcinoma of pancreas

← Back to all trials